Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year [Yahoo! Finance]
GeneDx Holdings Corp. - Class A (WGS)
Company Research
Source: Yahoo! Finance
It's considered a defensive sector, but it still contains stocks that can shoot through the roof, given the right conditions. This year, the stars aligned for GeneDx Holdings (NASDAQ: WGS) , a genetic testing specialist. The stock rose a whopping 6,070% during the 12-month period ended Nov. 13. To put this gain in perspective, Nvidia 's legendary run over the past five years delivered a return of just 2,700%. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free » Of course, everyday investors want to know if the genetic testing stock can climb even higher. Let's look at the reasons it's risen so far to find out if it deserves a spot in your portfolio. In 2022, Sema4 acquired GeneDx, which was at the time a wholly owned subsidiary of Opko Health . Sema4 was employing artificial intelligence ( AI ) applications to build models of human health, and adding GeneDx's genome and exome sequencing operation kicked the business into h
Show less
Read more
Impact Snapshot
Event Time:
WGS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WGS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WGS alerts
High impacting GeneDx Holdings Corp. - Class A news events
Weekly update
A roundup of the hottest topics
WGS
News
- GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx DiscoverBusiness Wire
- GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate SecretaryBusiness Wire
- New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic YieldsBusiness Wire
- GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual MeetingBusiness Wire
- GeneDx Holdings Corp. (NASDAQ: WGS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $54.00 to $70.00. They now have a "neutral" rating on the stock.MarketBeat
WGS
Earnings
- 10/29/24 - Miss
WGS
Sec Filings
- 11/21/24 - Form 144
- 11/20/24 - Form SC
- 11/19/24 - Form SC
- WGS's page on the SEC website